|
Racial, ethnic, and socioeconomic disparities in treatment outcomes in patients (pts) with diffuse large B-cell lymphoma (DLBCL): A U.S. real-world study using a de-identified electronic health record (EHR)-derived database. |
| |
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche |
| |
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
| |
|
|
Stock and Other Ownership Interests - Genentech |
| |
|
|
Stock and Other Ownership Interests - Roche |
| |
|
|
Stock and Other Ownership Interests - Roche |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; Pharmacyclics; Seagen |
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Flatiron Health; Genentech; Janssen; Novartis |
Research Funding - Celgene; Debiopharm Group; DTRM; TG Therapeutics |
Travel, Accommodations, Expenses - Bayer; Celgene |